Vimarsana
Biggest News Aggregation in the World

Page 20 - Vascular Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vascular Access Today - Breaking & Trending Today

When Should Those With End-Stage Kidney Disease Forego Dialysis? - Vimarsana News

When Should Those With End-Stage Kidney Disease Forego Dialysis?

Australia and the UK have long had programs whereby some elderly patients with end-stage kidney disease, or those with many comorbidities, opt to forego dialysis, but the US has lagged behind.

A One-of-a-Kind Lifeline: A First Responder's Kidney Health Journey - Vimarsana News

A One-of-a-Kind Lifeline: A First Responder's Kidney Health Journey

(NewsUSA) - Like the more than 25 million first responders in the United States, Jeff Cooper, a former deputy in the Broward County Polygraph Unit, took an oath to protect

Investment Analysts' Recent Ratings Changes for Teleflex (TFX) - Vimarsana News

Investment Analysts' Recent Ratings Changes for Teleflex (TFX)

Several brokerages have updated their recommendations and price targets on shares of Teleflex (NYSE: TFX) in the last few weeks: 5/11/2022 – Teleflex was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 5/9/2022 – Teleflex is now covered by analysts at Bank of America Co.. They set a “neutral” rating […]

Potential Risk From Fresenius Dialysis Units, FDA Warns - Vimarsana News

Potential Risk From Fresenius Dialysis Units, FDA Warns

The US Food and Drug Administration sent a letter to clinicians on May 6 warning of potentially toxic PCB exposure from certain hemodialysis machines sold by Fresenius Medical Care.

Diminishing mRNA Vaccine Responses in Dialysis Patients - Vimarsana News

Diminishing mRNA Vaccine Responses in Dialysis Patients

Immune responses towards SARS-CoV-2 vaccines among patients undergoing hemodialysis may decrease over time, highlighting the potential need for additional doses in this group.